BSL-BIOSERVICE Scientific Laboratories GmbH

What BSL-BIOSERVICE Scientific Laboratories GmbH does

BSL-BIOSERVICE Scientific Laboratories Munich GmbH is a Germany-based Contract Research Organization (CRO) specializing in preclinical in vivo safety and toxicity testing for regulated industries. Operating from its headquarters in Planegg/Munich under a Eurofins preferred-partner structure (since the 2015 carve-up that integrated its in vitro services into Eurofins BioPharma Product Testing Munich), the company delivers GLP-compliant acute, subchronic, and chronic toxicology studies, ISO 10993 biocompatibility testing, medical device implantation studies across multiple species, REACH directive safety studies, and GMP/GLP-compliant batch release bioassays aligned to EP, USP, BP, and JP pharmacopoeia standards. The firm's triple accreditation stack (GLP, GMP, DIN EN ISO 17025, plus AAALAC International since February 2014) positions it as a recognized provider of regulatory-grade safety data across five industry verticals: biopharmaceuticals/biologics/ATMPs, chemicals (REACH), medical devices, agrochemicals/biocides, and food.

The company's service portfolio is organized into three categories — Drug Discovery, Safety Assessment, and Manufacturing Support — and spans ADME, PK/PD, immunotoxicology, immunogenicity, pharmacology and proof-of-concept studies, DART, carcinogenicity, ecotoxicology, and pharmacopoeia testing. Core technical differentiators include proprietary surgical techniques for orthopedic, cardiovascular, ocular, and dental device implantation in rat, guinea pig, rabbit, sheep, and pig/mini-pig models; custom study designs matched to client regulatory submissions; and access to multi-site program coordination through the Safety Alliance (a curated European CRO network) and bilateral partnerships with Product Safety Labs (US) and Pharmacology Discovery Services (Taiwan).

BSL BIOSERVICE generates revenue on a fee-for-service, project-by-project basis through direct enterprise sales to pharmaceutical, biotech, chemical, medical device, agrochemical, and food clients. Go-to-market is concentrated on direct B2B engagement via industry-specific contact forms, conference participation (Eurotox, SOT, ICT, Nordic Life Science Days), and structured inbound referrals through the Eurofins global laboratory network and Eurofins REACH Taskforce. Pricing is quote-based and not publicly disclosed; revenue mechanics reflect project complexity, species, and regulatory standard rather than standardized unit pricing. The company has 11–50 employees and operates as a privately held GmbH under Eurofins ownership.

Name

BSL-BIOSERVICE Scientific Laboratories GmbH

Legal name

BSL BIOSERVICE Scientific Laboratories Munich GmbH

Website

https://bioservice.com

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

11–50 employees

Short description

BSL-BIOSERVICE Scientific Laboratories GmbH is a German preclinical Contract Research Organization delivering GLP-compliant in vivo safety testing, ISO 10993 biocompatibility studies, and GMP batch release bioassays to pharmaceutical, chemical, medical device, agrochemical, and food industry clients as a Eurofins preferred partner.

Ownership category

akta.pro rank

Product category

Preclinical Contract Research Services

NAICS

Testing Laboratories and Services (541380), Testing Laboratories and Services (54138), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Toxicology & Safety Assessment CROs (GLP) (HLAGAAAC)

akta.pro secondary industries

Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK), Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Toxicology & Therapeutic Drug Monitoring Laboratories (HLAFAMAF), Food Safety Certification Bodies (ISO 22000, FSSC 22000, BRCGS, SQF) (AFALAAAC)

Keywords

• Preclinical safety testing
• Contract research organization
• Biocompatibility testing
• GLP toxicology studies
• Medical device testing

Headquarters

HQ city

Planegg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Contract Research Services (CRO): BSL BIOSERVICE generates revenue through fee-for-service contract research engagements, providing preclinical safety testing, toxicity studies, biocompatibility testing, and manufacturing support services on a project-by-project basis to pharmaceutical, chemical, medical device, agrochemical, and food companies. Projects are tailored to client regulatory requirements (GLP, GMP, ISO 17025) and typically span from early drug discovery through batch release and market approval.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

BSL BIOSERVICE is a Contract Research Organization (CRO) providing GLP-compliant preclinical safety testing services for regulated industries. Its core offerings span drug discovery support, safety assessment (toxicology, biocompatibility, medical device implantation studies), and manufacturing support (batch release and pharmacopoeia testing) for pharmaceutical, chemical, medical device, agrochemical, and food industry clients.

Product overview

BSL BIOSERVICE is a Contract Research Organization (CRO) offering preclinical safety testing services organized into three main service categories: Drug Discovery Services (pharmacology, proof of concept, efficacy testing), Safety Assessment Services (toxicology, biocompatibility testing, safety pharmacology), and Manufacturing Support (batch release testing, pharmacopoeia testing). The company provides specialized testing across five industry verticals: Biopharmaceuticals/Biologics/ATMPs, Chemicals (including REACH compliance), Medical Devices (ISO 10993 biocompatibility and implantation studies), Agrochemicals & Biocides, and Food. Services are delivered through in vivo and in vitro study designs, with partnerships with Eurofins BioPharma Product Testing Munich and other specialized laboratories extending their capabilities.

Differentiator

Problem solved

Functional benefit

Products and services

• Drug Discovery Services

Quantifiable outcome

• Over 30 years of specialized preclinical testing experience
• +3 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Seven partnerships are on record, tiered minor and core.

• Zentrum für Präklinische Forschung, Klinikum Rechts der Isar, MunichminorStrategic or Co-development Partner · 1 January 2017In 2017, the Zentrum für Präklinische Forschung from Klinikum Rechts der Isar in Munich was successfully accredited by AAALAC together with BSL BIOSERVICE to conduct animal testing, expanding the network of accredited preclinical research capabilities.
• Eurofins (global network)coreStrategic or Co-development Partner · 1 January 2015BSL BIOSERVICE is a preferred partner of Eurofins, a world leader in analytical testing. The company is part of a global scientific network offering services from discovery and preclinical testing to market approval. In 2015, the in vitro services were integrated into Eurofins BioPharma Product Testing Munich GmbH, while BSL BIOSERVICE retained the in vivo safety testing operations.
• Eurofins BioPharma Product Testing MunichcoreStrategic or Co-development PartnerPreferred partner relationship with Eurofins BioPharma Product Testing Munich. In 2015, all in vitro services of BSL BIOSERVICE were integrated into Eurofins BioPharma Product Testing. BSL BIOSERVICE retains in vivo safety testing services and operates as a preferred partner of Eurofins. Services include shared nonclinical development programs, regulatory submission support, and client referrals within the Eurofins network. BSL BIOSERVICE is also part of the Eurofins REACH Taskforce.
• Eurofins Agroscience ServicesminorStrategic or Co-development PartnerPartnership with Eurofins Agroscience Services to offer a comprehensive range of field and laboratory studies as well as regulatory support for agrochemical and biocide safety and efficacy determination.
• Product Safety Labs (PSL)minorStrategic or Co-development PartnerPartnership with Product Safety Labs (PSL) in the United States to offer efficacy models and support for drug discovery and development programs across multiple therapeutic areas.
• Pharmacology Discovery ServicesminorStrategic or Co-development PartnerPartnership with Pharmacology Discovery Services in Taiwan to provide efficacy models and proof-of-concept studies including infection and vaccination test designs under biosafety level 2, supplementing BSL BIOSERVICE's in vivo pharmacology services.
• Safety AllianceminorStrategic or Co-development PartnerBSL BIOSERVICE is part of the Safety Alliance, a network of selected high-quality complementary CROs located in Europe. The alliance serves as a coordinating and monitoring function for multi-site studies between different CROs to deliver high quality standards to clients.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

Emerging players

• Pharmaron: China-headquartered CRO with growing preclinical safety, DMPK, and bioanalytical capabilities in the US/UK. Comparable to BSL on GLP toxicology and ADME/PK services for IND-enabling programs.

Broad incumbents

• Wuxi AppTec: Global CRO offering preclinical toxicology, bioanalysis, and IND-enabling services for pharma and biotech. Comparable to BSL in GLP in vivo safety testing but with much broader geographic footprint and integrated discovery-to-clinical capabilities.
• Labcorp (Covance): Large CRO with preclinical safety assessment, bioanalytical, and central laboratory capabilities. Comparable to BSL on GLP-compliant toxicology and IND-enabling study design, but serves global biopharma at significantly greater scale.
• Charles River Laboratories: Global preclinical CRO offering in vivo safety/toxicology, bioanalysis, and medical-device testing across multiple species and geographies. Direct overlap with BSL's GLP toxicology and medical-device biocompatibility services, but at materially larger scale and broader portfolio.

Direct peers

• Product Safety Labs (PSL): US-based preclinical CRO specializing in toxicology, efficacy models, and drug discovery support. Active partnership partner of BSL BIOSERVICE and directly comparable on GLP-compliant in vivo safety studies across regulated industries.
• Eurofins Agroscience Services: Eurofins agrochemical and biocide testing services division, partnered with BSL for field and laboratory studies. Directly comparable on agrochemical toxicology, ecotoxicology, and regulatory support services.
• Citoxlab (a Charles River company): Specialty preclinical CRO acquired by Charles River, offering general toxicology, reproductive toxicology, and safety pharmacology. Direct overlap with BSL's GLP in vivo toxicology offering.
• Sequani: UK-based preclinical CRO with strong general and reproductive toxicology capabilities under GLP. Comparable size and service focus to BSL, particularly for regulated-industry toxicology studies.
• ITR Laboratories Canada: Preclinical CRO offering reproductive and developmental toxicology, general toxicology, and bioanalysis under GLP. Comparable niche focus on regulatory in vivo safety testing with similar client mix of pharma, chemical, and consumer-product companies.
• Eurofins BioPharma Product Testing Munich: Sister entity under the Eurofins umbrella that absorbed BSL's in vitro services in 2015. Directly comparable service portfolio (preclinical safety and bioanalytical testing), now often co-delivered with BSL through the preferred-partner arrangement.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bsl-bioservice-scientific-laboratories-gmbh

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BSL-BIOSERVICE Scientific Laboratories GmbH